| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |